Search research articles
Contact Us
Filters
Showing results (241-250 of 262) with videos related to
Page
of 27
Sort By:
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 29, 2024
Factors associated with lack of clinical improvement after vein ablation in the vascular quality initiative
Paula Pinto Rodríguez, Michael Fassler, Andrea Obi, et al.
Current Drug Metabolism
|
October 16, 2008
The use of metabolising systems for in vitro testing of endocrine disruptors
M N Jacobs, W Janssens, U Bernauer, et al.
Molecular Cancer Therapeutics
|
March 16, 2017
Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles
Nicolas Floc'h, Susan Ashton, Paula Taylor, et al.
Archives of Toxicology
|
June 29, 2020
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
Miriam N Jacobs, Annamaria Colacci, Raffaella Corvi, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 14, 2022
Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop
Carl Westmoreland, Hans J Bender, John E Doe, et al.
The Journal of Clinical Investigation
|
April 17, 2019
Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis
Vinita Yadav, Liguo Chi, Raymond Zhao, et al.
Experimental Neurology
|
February 6, 2025
Mineral coated microparticles delivering Interleukin-4, Interleukin-10, and Interleukin-13 reduce inflammation and improve function after spinal cord injury in a rat
Daniel J Hellenbrand, Jae Sung Lee, Ethan J Mickelson, et al.
Acta Psychiatrica Scandinavica
|
February 7, 2020
Polygenic liability for schizophrenia and childhood adversity influences daily-life emotion dysregulation and psychosis proneness
L-K Pries, B Klingenberg, C Menne-Lothmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma
Ariana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Oncogene
|
October 31, 2012
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo
C Eberlein, J Kendrew, K McDaid, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 262) with videos related to
Sort By:
Page
of 27
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 29, 2024
Factors associated with lack of clinical improvement after vein ablation in the vascular quality initiative
Paula Pinto Rodríguez, Michael Fassler, Andrea Obi, et al.
Current Drug Metabolism
|
October 16, 2008
The use of metabolising systems for in vitro testing of endocrine disruptors
M N Jacobs, W Janssens, U Bernauer, et al.
Molecular Cancer Therapeutics
|
March 16, 2017
Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles
Nicolas Floc'h, Susan Ashton, Paula Taylor, et al.
Archives of Toxicology
|
June 29, 2020
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
Miriam N Jacobs, Annamaria Colacci, Raffaella Corvi, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 14, 2022
Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop
Carl Westmoreland, Hans J Bender, John E Doe, et al.
The Journal of Clinical Investigation
|
April 17, 2019
Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis
Vinita Yadav, Liguo Chi, Raymond Zhao, et al.
Experimental Neurology
|
February 6, 2025
Mineral coated microparticles delivering Interleukin-4, Interleukin-10, and Interleukin-13 reduce inflammation and improve function after spinal cord injury in a rat
Daniel J Hellenbrand, Jae Sung Lee, Ethan J Mickelson, et al.
Acta Psychiatrica Scandinavica
|
February 7, 2020
Polygenic liability for schizophrenia and childhood adversity influences daily-life emotion dysregulation and psychosis proneness
L-K Pries, B Klingenberg, C Menne-Lothmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma
Ariana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Oncogene
|
October 31, 2012
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo
C Eberlein, J Kendrew, K McDaid, et al.
Page
of 27